FDA approves Lap-Band for millions more patients

Feb 16, 2011

(AP) -- Cosmetic drug and device maker Allergan Inc. says it has received approval to market its stomach-shrinking Lap-Band to millions more patients who are less obese than those currently using the device.

The expanded approval to patients with a between 30 and 40 and one weight-related medical condition, such as . Patients must also have previously attempted other weight loss strategies, like diet and exercise.

Allergan said roughly 37 million American patients meet the new criterion for the device. The adjustable band has been available in the U.S. since 2001.

A ring is placed over the top of the stomach and inflated with saline to tighten it and restrict how much food can enter and pass through the stomach.

Explore further: Anti-cholinergic drugs impair physical function in elderly patients

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Panel recommends expanding use of stomach bands

Dec 04, 2010

(AP) -- About 12 million more obese Americans could soon qualify for surgery to implant a small, flexible stomach band designed to help them lose weight by dramatically limiting their food intake. The Food ...

FDA approves Botox for migraine headaches

Oct 15, 2010

(AP) -- Federal health officials approved the wrinkle-smoothing injection Botox for migraine headaches on Friday, giving drugmaker Allergan clearance to begin marketing its drug to patients with a serious history of the ...

No scars: New obesity surgery goes through mouth

Jun 03, 2009

(AP) -- Doctors are testing a new kind of obesity surgery without any cuts through the abdomen, snaking a tube as thick as a garden hose down the throat to snap staples into the stomach. The experimental, ...

Soft drink could enhance effects of an anti-cancer drug

Oct 13, 2010

Experiments with an artificial stomach suggest that a popular lemon-lime soft drink could play an unexpected role in improving the effectiveness of an oral anticancer drug. The experiments produced evidence that patients ...

Recommended for you

FDA to start regulating lab-developed tests

18 hours ago

(AP)—The Food and Drug Administration announced Thursday it will begin regulating laboratory-developed tests, a growing class of medical diagnostics that have never before been subject to federal oversight.

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

neiorah
not rated yet Feb 18, 2011
Why do they have to have diabetes first. Use it as a preventative measure since weight caused diabetes is caused by too much sugar and a resistance to insulin. Not good to wait until after the damage is done.